A Case of Progesterone-Induced Anaphylaxis, Cyclic Urticaria/Angioedema, and Autoimmune Dermatitis
article
OA: closed
CC0
⤵ 1 in-corpus citation
AI-generated summary
This case report details a patient with progesterone-induced anaphylaxis, cyclic urticaria, and autoimmune dermatitis who responded to gonadotropin-releasing hormone agonist therapy, which eliminated specific progesterone antibodies.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
OBJECTIVE: Women have exhibited anaphylaxis, urticaria/angioedema, and autoimmune progesterone dermatitis (APD) coinciding with the progesterone premenstrual rise. We report a detailed immunological evaluation of such a woman responsive to a gonadotropin hormone-releasing agonist (GHRA). METHODS: Skin testing, enzyme-linked immunosorbent assays (ELISAs), leukocyte histamine release (LHR), and inhibition assays were performed to demonstrate progesterone immunoresponsiveness. RESULTS: Serum specific-progesterone immunoglobulin G (IgG) and IgE were detected initially and disappeared 6 months after GHRA treatment. Dose-response LHR using patient basophils was observed for different hormones but after 3 months persisted only for 5β-pregnanediol. Preincubation with mouse antiprogesterone monoclonal antibody (PmAb) or mifepristone, a progesterone inhibitor, over a range of doses inhibited specific progesterone-induced LHR. Experiments with varying progesterone concentrations and a fixed dose of anti-IgE resulted in 100% LHR at a concentration as low as 0.016 nmol/mL, which, without anti-IgE, failed to release histamine. CONCLUSIONS: This is the first report of combined recurrent anaphylaxis, cyclic urticaria/angioedema, and APD induced by immunoresponsiveness to progesterone.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cited by (1)
References (40)
- doi:10.1016/0021-8707(45)90035-9 via openalex
- doi:10.1001/archderm.1977.01640040034003 via openalex
- doi:10.1056/nejm198907273210405 via openalex
- doi:10.1080/00016489850182314 via openalex
- doi:10.1097/00004836-199709000-00022 via openalex
- doi:10.1067/mjd.2002.121345 via openalex
- doi:10.1111/j.1365-2133.1994.tb06897.x via openalex
- doi:10.1111/j.1365-2133.2008.08950.x via openalex
- doi:10.1056/nejm198411083111907 via openalex
- doi:10.1111/j.1365-4632.2008.03395.x via openalex
- doi:10.1084/jem.120.4.507 via openalex
- doi:10.1001/archderm.1964.01590260047008 via openalex
- doi:10.1097/00006254-198506000-00018 via openalex
- doi:10.1210/er.2007-0022 via openalex
- doi:10.1016/s1081-1206(10)61838-8 via openalex
- doi:10.1016/0091-6749(87)90033-9 via openalex
- doi:10.1016/s1079-2104(98)90287-6 via openalex
- doi:10.2310/6620.2006.05045 via openalex
- doi:10.1016/0091-6749(89)90388-6 via openalex
- doi:10.1111/j.1365-2230.2004.01516.x via openalex
- doi:10.3109/09513590009167688 via openalex
- doi:10.1111/j.1365-2133.1995.tb02759.x via openalex
- W2178797281 via openalex
- W2277581934 via openalex
- W2464129513 via openalex
- W2470476212 via openalex
- doi:10.1038/292454a0 via openalex
- doi:10.1159/000250305 via openalex
- doi:10.1073/pnas.86.14.5542 via openalex
- doi:10.1038/nri2458 via openalex
- doi:10.1016/0190-9622(95)90398-4 via openalex
- doi:10.1001/jama.1964.03070140041004 via openalex
- doi:10.1111/j.1600-0897.2006.00373.x via openalex
- doi:10.4049/jimmunol.172.10.5893 via openalex
- doi:10.1097/00006254-198804000-00018 via openalex
- doi:10.1016/0091-6749(71)90025-x via openalex
- doi:10.1111/j.1365-2230.2008.02963.x via openalex
- doi:10.4049/jimmunol.150.4.1503 via openalex
- W2127192873 via openalex
- doi:10.1677/joe-07-0317 via openalex
Cited by (1)
Source provenance
- openalex
- last seen: 2026-05-11T05:18:36.020566+00:00
- unpaywall
- last seen: 2026-09-05T06:29:56.012541+00:00
License: CC0
· commercial use OK